1076 related articles for article (PubMed ID: 19821482)
1. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
[TBL] [Abstract][Full Text] [Related]
2. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
4. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
9. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
10. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
12. The role of XBP1s in the metastasis and prognosis of hepatocellular carcinoma.
Wu S; Du R; Gao C; Kang J; Wen J; Sun T
Biochem Biophys Res Commun; 2018 Jun; 500(3):530-537. PubMed ID: 29627568
[TBL] [Abstract][Full Text] [Related]
13. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN
Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862
[TBL] [Abstract][Full Text] [Related]
14. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
17. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Lee TK; Poon RT; Yuen AP; Ling MT; Kwok WK; Wang XH; Wong YC; Guan XY; Man K; Chau KL; Fan ST
Clin Cancer Res; 2006 Sep; 12(18):5369-76. PubMed ID: 17000670
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
[TBL] [Abstract][Full Text] [Related]
19. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repressor snail and progression of human hepatocellular carcinoma.
Sugimachi K; Tanaka S; Kameyama T; Taguchi K; Aishima S; Shimada M; Sugimachi K; Tsuneyoshi M
Clin Cancer Res; 2003 Jul; 9(7):2657-64. PubMed ID: 12855644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
